A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis

Critical Reviews in Toxicology

Volumn 39, Issue 2, 2009, Pages 97-138

  Hattis, D ^a   Chu, M ^b   Rahmioglu, N ^a   Goble, R ^a   Verma, P ^a   Hartman, K ^a   Kozlak, M ^a  

^a CLARK UNIVERSITY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cancer; Initiation; Mechanisms; Progression; Promotion

Indexed keywords

CARCINOGEN;

CARCINOGENESIS; CELL COMMUNICATION; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; ENZYME ACTIVATION; GENE SILENCING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MUTAGENESIS; NONHUMAN; REVIEW; STEM CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DISEASE PROGRESSION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MUTAGENS; NEOPLASMS; TIME FACTORS;

EID: 60549084518     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440802307467     Document Type: Review

References (354)

1. Abdellatif, A., Al-Tonsy, A.H., Awad, M.E., Roberfroid, M. and Khan, M.N. (2003). Peroxisomal enzymes and 8-hydroxydeoxyguanosine in rat liver treated with perfluorooctanoic acid. Dis. Markers 19(1):19-25.
2. Ahuja, N., and Issa, J.P. (2000). Aging, methylation and cancer. Histol. Histopathol. 15(3):835-842.
3. Alexander, F.E., Patheal, S.L., Biondi, A., Brandalise, S., Cabrera, M.E., Chan, L.C., Chen, Z., Cimino, G., Cordoba, J.C., Gu, L.J., Hussein, H., Ishii, E., Kamel, A.M., Labra, S., Magalhaes, I.Q., Mizutani, S., Petridou, E., de Oliveira, M.P., Yuen, P., Wiemels, J.L., and Greaves, M.F. (2001). Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 61(6):2542-2546.
4. Andersen, M.E., and Robinson, D.E. (2001). Risk assessment methods: Chloroform as a case study. In Microbial Pathogens and Disinfection By-Products in Drinking Water: Health Risks and Management of Risks, 353-366. International Life Sciences Institute, Washington, DC.
5. Anderson, R.A., Weaver, A.M., Cummings, P.T., and Quaranta, V. (2006). Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 27:1-11.
6. Anna, C.H., Iida, M., Sills, R.C., and Devereux, T.R. (2003). Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Toxicol. Appl. Pharmacol. 190(2):135-145.
7. Anna, C.H., Sills, R.C., Foley, J.F., Stockton, P.S., Ton, T.V., and Devereux, T.R. (2000). Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. Cancer Res. 60(11):2864-2868.
8. Arnott, C.H., Scott, K.A., Moore, R.J., Hewer, A., Phillips, D.H., Parker, P., Balkwill, F.R., and Owens, D.M. (2002). Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene 21(31):4728-4738.
9. Babbar, N., and Casero, R.A.J. (2006). Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: A potential mechanism for inflammation-induced carcinogenesis. Cancer Res. 66(23):11125-11130.
10. Bachelor, M.A., and Bowden, G.T. (2004). UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. Semin. Cancer Biol. 14:131-138.
11. Baik, I., Devito, W.J., , Ballen, K., Becker, P.S., Okulicz, W., Liu, Q., Delpapa, E., Lagiou, P., Sturgeon, S., Trichopoulos, D., Quesenberry, P.J., and Hsieh, C.C. (2005). Association of fetal hormone levels with stem cell potential: Evidence for early life roots of human cancer. Cancer Res. 65(1):358-363.
12. Baker, T.K., Kwiatkowski, A.P., Madhukar, B.V., and Klaunig, J.E. (1995). Inhibition of gap junctional intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat hepatocytes. Carcinogenesis 16(10):2321-2326.
13. Bal, W., Schwerdtle, T., and Hartwig, A. (2003). Mechanism of nickel assault on the zinc finger of DNA repair protein XPA. Chem. Res. Toxicol. 16(2):242-248
14. Barton, H.A., Cogliano, V.J., Flowers, L., Valcovic, L., Setzer, R.W., and Woodruff, T.J. (2005). Assessing susceptibility from early-life exposure to carcinogens. Environ. Health Perspect. 113:1125-1133.
15. Battalora, M.S.J., Spalding, J.W., Szczesniak, C.J., Cape, J.E., Morris, R.J., Trempus, C.S., Bortner, C.D., Lee, B.M., and Tennant, R.W. (2001). Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse. Carcinogenesis 22(4):651-659.
16. Baylin, S.B., and Herman, J.G. (2000). DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 6(4):168-174.
17. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M., and Issa, J.P. (1998). Alterations in DNA methylation: A fundamental aspect of neoplasia.Adv. Cancer Res. 72:141-196.
18. Baylin, S.B., and Chen, W.Y. (2005). Aberrant gene silencing in tumor progression: Implications for control of cancer. Cold Spring Harbor Symp. Quant. Biol. Symp. 70:427-433.
19. Belinsky, S.A., Klinge, D.M., Stidley, C.A., Issa, J.P., Herman, J.G., March, T.H., and Baylin, S.B. (2003). Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res. 63(21):7089-7093.
20. Bender, R.P., Lindsey, R.H.J., Burden, D.A., and Osheroff, N. (2004). N-Acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison. Biochemistry 43(12):3731-3739.
21. Bennett-Baker, P.E., Wilkowski, J., and Burke, D.T. (2003). Age-associated activation of epigenetically repressed genes in the mouse. Genetics 165(4):2055-2062.
22. Berenblum, I. (1941). The cocarcinogenic action of croton resin. Cancer Res. 1:44-48.
23. Berenblum, I., and Shubik, P. (1949). The persistence of latent tumour cells induced in the mouse's skin by a single application of 9:10-dimethyl-1:2-benzanthracene. Br. J. Cancer 3(3):384-386.
24. Bereneblum, I., and Shubik, P. (1947). A new, quantitative approach to the study of the stages of chemical carcinogenesis in the mouse's skin. Br. J. Cancer 1:383-391.
25. Bezdecny, S.A., Karmaus, P., Roth, R.A., and Ganey, P.E. (2007). 2,2′,4,4′-Tetrachlorobiphenyl upregulates cyclooxygenase-2 in HL-60 cells via p38 mitogen-activated protein kinase and NF-kappaB. Toxicol. Appl. Pharmacol. 221:285-294.
26. Bialkowski, K., Bialkowska, A., and Kasprzak, K.S. (1999). Cadmium(II), unlike nickel(II), inhibits 8-oxo-dGTPase activity and increases 8-oxo-dG level in DNA of the rat testis, a target organ for cadmium(II) carcinogenesis. Carcinogenesis 20:1621-1624.
27. Birnbaum, L.S., and Fenton, S.E. (2003). Cancer and developmental exposure to endocrine disruptors. Environ. Health Perspect. 111(4):389-394.
28. Blanquart, C., Mansouri, R., Paumelle, R., Fruchart, J.C., Staels, B., and Glineur. C. (2004). The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha Mol. Endocrinol. 18(8):1906-1918.
29. Blot, W.J., Harrington, J.M., Toledo, A., Hoover, R., Heath, C.W.J., and Fraumeni, J.F.J. (1978). Lung cancer after employment in shipyards during World War II. N. Engl. J. Med. 299(12):620-624.
30. Bohning, D.E., Atkins, H.L., and Cohn, S.H. (1982). Long-term particle clearance in man:normal and impaired Ann. Occup. Hyg. 26:259-271.
31. Boobis, A.R., Cohen, S.M., Dellarco, V., McGregor, D., Meek, M.E., Vickers, C., Willcocks, D., and Farland, W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36(10):781-792.
32. Bouchardy, C., Morabia, A., Verkooijen, H.M., Fioretta, G., Wespi, Y., and Schafer. P. (2006). Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy. BMC Cancer 6:78.
33. Boutwell, R.K. (1964). Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res. 4:207-250.
34. Boutwell, R.K., Caruso, R.L., Upham, B.L., Harris, C., and Trosko, J.E. (2005). Biphasic lindane-induced oxidation of glutathione and inhibition of gap junctions in myometrial cells. Toxicol. Sci. 86(2):417-426.
35. Brock, M.V., Herman, J.G., and Baylin, S.B. (2007). Cancer as a manifestation of aberrant chromatin structure. Cancer J. 13(1):3-8.
36. Brown, N.M., Manzolillo, P.A., Zhang, J.X., Wang, J., and Lamartiniere, C.A. (1988). Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 19:1623-1629.
37. Budunova, I.V., Carbajal, S., and Slaga, T.J. (1996). Effect of diverse tumor promoters on the expression of gap-junctional proteins connexin (Cx)26, Cx31.1, and Cx43 in SENCAR mouse epidermis. Mol. Carcinogen. 15(3):202-214.
38. Buell, J.F., Gross, T.G., and Woodle, E.S. (2005). Malignancy after transplantation Transplantation 80:S254-S264.
39. Butterworth, B.E. (2006). A classification framework and practical guidance for establishing a mode of action for chemical carcinogens. Regul. Toxicol. Pharmacol. 45:9-23.
40. Cai, S.X., Zhang, C.H., Zhang, X., and Morinaga, K. (2001). Epidemiology of occupational asbestos-related diseases in China. Ind. Health 39(2):75-83.
41. Carter, J.H., Carter, H.W., Deddens, J.A., Hurst, B.M., George, M.H., and DeAngelo, A.B. (2003). Carcinogenesis in the male B6C3F mouse given the drinking water chemical dichloroacetic acid. Environ. Health Perspect. 111:53-64.
42. Caruso, R.L., Upham, B.L., Harris, C., and Trosko, J.E. (2005). Biphasic lindane-induced oxidation of glutathione and inhibition of gap junctions in myometrial cells. Toxicol. Sci. 86(2):417-426.
43. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., and Nishizuka, Y. (1982). Direct activation of calcium-activated phospolipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257(13):7847-7851.
44. Cattley, R.C., Marsman, D.S., and Popp, J.A. (1991). Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver. Carcinogenesis 12:469-473.
45. Cervello, M., Foderaa, D., Florena, A.M., Soresi, M., Tripodo, C., D'Alessandro, N., and Montalto, G. (2005). Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: Possible role in tumor promotion and angiogenesis. World J. Gastroenterol. 11(30):4638-4643.
46. Chapman, J., and Webster, A.C. (2004). Cancer report: ANZDATA Registry 2004 Report, 2004:99, quoted by Buell, J.F., Gross, T.G., and Woodle, E.S. (2005). Malignancy after transplantation. Transplantation 80:S254-S264.
47. Chida, K., Hara, T., Hirai, T., Konishi, C., Nakamura, K., Nakao, K., Aiba, A., Katsuki, M., and Kuroki. T. (2003). Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis Cancer Res. 2003(10):2404-2408.
48. Chu, K.C., Brown, C.C., Tarone, R.E., and Tan, W.Y. (1987). Differentiating among proposed mechanisms for tumor promotion in mouse skin with the use of the multievent model for cancer. JNCI 79:789-796.
49. Clemens, M.J., Trayner, I., and Menaya, J. (1992). The role of protein kinase C isoenzymes in the regulatio of cell proliferation and differentiation. J. Cell Sci. 103:881-887.
50. Cohen, S.M., Meek, M.E., Klaunig, J.E., Patton, D.E., and Fenner-Crisp, P.A. (2003). The human relevance of information on carcinogenic modes of action: Overview. Crit. Rev. Toxicol. 33(6):581-589.
51. Colnot, S., Decaens, T., Niwa-Kawakita, M., Godard, C., Hamard, G., Kahn, A., Giovannini, M., and Perret, C. (2004). Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 101(49):17216-17221.
52. Conolly, R.B., and Lutz, W.K. (2004). Nonmonotonic dose-response relationships:mechanistic basis, kinetic modeling, and implications for risk assessment. Toxicol. Sci. 77(1):151-157.
53. Conolly, R.B., and Andersen, M.E. (1997). Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: Evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter. Toxicol. Appl. Pharmacol. 146(2):281-293.
54. Constan, A.A., Wong, B.A., Everitt, J.I., and Butterworth, B.E. (2002). Chloroform inhalation exposure conditions necessary to initiate liver toxicity in female B6C3F1 mice. Toxicol. Sci. 66(2):201-208.
55. Corpet, D.E., and Pierre, F. (2005). How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur. J. Cancer 41:1911-1922.
56. Croci, D.O., Zacarias Fluck, M.F., Rico, M.J., Matar, P., Rabinovich, G.A., and Scharovsky, O.G. (2007). Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol. Immunother. June 15 [Epub ahead of print].
57. Crump, K., Hoel, D., and Peto, R. (1976). Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36:2973-2979.
58. De Flora, S., and Ferguson, L.R. (2005). Overview of mechanisms of cancer chemopreventive agents. Mutat. Res. 591:8-15.
59. De la Torre, E., Davel, L., Jasnis, M.A., Gotoh, T., de Lustig, E.S., and Sales, M.E. (2005). Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice. Breast Cancer Res. 7(3):R345-352.
60. Dean, C.E., Jr., , Benjamin, S.A., Chubb, L.S., Tessari, J.D., and Keefe, T.J. (2002). Nonadditive hepatic tumor promoting effects by a mixture of two structurally different polychlorinated biphenyls in female rat livers. Toxicol. Sci. 66(1):54-61.
61. DeCastro, B.R., and Neuberg, D. (2007). The statistical performance of an MCF-7 cell culture assay evaluated using generalized linear mixed models and a score test. Stat. Med. 26(12):2501-2508.
62. DeCastro, B.R., Korrick, S.A., Spengler, J.D., and Soto, A. (2006). Estrogenic activity of polychlorinated biphenyls present in human tissue and the environment. Environ. Sci. Technol. 40(8):2819-2825.
63. Devereux, T.R., Anna, C.H., Foley, J.F., White, C.M., Sills, R.C., and Barrett, J.C. (1999). Mutation of beta-catenin is an early event in chemically-induced mouse hepatocellular carcinogenesis. Oncogene 18:4726-4733.
64. Devereux, T.R., Stern, M.C., Flake, G.P., Yu, M., Zhang, Z.Q., London, S.J., and Taylor, J.A. ( 2001). CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol. Carcinogen. 31(2):68-73.
65. Devoogdt, N., Revets, H., Kindt A., Liu, Y.Q., De, P., and Ghassabeh G.H. (2006). The tumor-promoting effect of TNF-alpha involves the induction of secretory leukocyte protease inhibitor. J. Immunol. 177(11):8046- 8052.
66. Dixon, K., and Kopras, E. (2004). Genetic alterations and DNA repair in human carcinogenesis. Semin. Cancer Biol. 14(6):441-448.
67. Douglas, D.B., Akiyama, Y., Carraway, H., Belinsky S.A, Esteller, M., Gabrielson, E., Weitzman, S., Williams, T., Herman, J.G., and Baylin, S.B. (2004). Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Cancer Res. 64(5):1611-1620.
68. Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J., and Schreiber, R.D. (2002). Cancer immunoediting:from immunosurveillance to tumor escape. Nat. Immunol. 3:991-998.
69. Durand, O., M., Kass, L., Piva, J., Sonnenschein, C., Soto, A.M., Luque E, H., and Munoz-de-Toro, M. (2007). Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats Environ. Health Perspect. 115:80-86.
70. Duss, S., Andre, S., Nicoulaz, A.L., Fiche, M. B., H., , Brisken, C., and Iggo, R.D. (2007). An estrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cell. Breast Cancer Res. 9(3):R38.
71. Duthie, S.J., Narayanan, S., Sharp, L., Little, J., Basten, G., and Powers, H. (2004). Folate, DNA stability and colo-rectal neoplasia. Proc. Nutr. Soc. 63(4):571-578.
72. Dybing, E. (2002). Development and implementation of the IPCS conceptual framework for evaluating mode of action of chemical carcinogens. Toxicology 181-182:121-125.
73. Eberhart, C., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S., and Dubois, R.N. (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188.
74. Eblin, K., Bredfeldt, T.G., Buffington, S., and Gandolfi, A.J. (2007). Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: Role in arsenic-induced carcinogenesis. Toxicol. Sci. 95(2):321-330.
75. El-Abaseri, T.B., Putta, S., and Hansen, L.A. (2006). Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor. Carcinogenesis 27:225-231.
76. Elcombe, C.R., Odum, J., Foster, J.R., Stone, S., Hasmall, S., Soames, A., and Kimber, I., Ashby, J. (2002). Prediction of rodent nongenotoxic carcinogenesis: Evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. Environ. Health Perspect. 110:363-375.
77. Ellinger-Ziegelbauer, H., Stuart, B., Wahle, B., Bomann, W., and Ahr, H.J. (2005). Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 575(1-2):61-84.
78. Esteller, M., Risques, R.A., Toyota, M., Capella, G., Moreno, V., Peinado, M.A., Baylin, S.B., and Herman, J. (2001). Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res. 61(12):4689-4692.
79. Esteller, M., Sparks, A., Toyota, M., Sanchez-Cespedes, M., Capell, G., Peinado, M.A., Gonzalez, S., Tarafa, G., Sidransky, D., Meltzer, S.J., Baylin, S.B., and Herman, J. (2000a). Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60(16):4366-4371.
80. Esteller, M., Toyota, M., Sanchez-Cespedes, M., Capella, G., Peinado, M.A., Watkins, D.N., Issa, J.P., Sidransky, D., Baylin, S.B., and Herman, J.G. (2000b). Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 60(9):2368-2371.
81. Ewing, W.M., Conti, C.J., Kruszewski, F.H., Slaga, T.J., and DiGiovanni, J. (1988a). Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Cancer Res. 48:7048-7054.
82. Ewing, W.M., Crysup, S.E., Phillips, J.L., Slaga, T.J., and DiGiovanni, J. (1988b). Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation. Carcinogenesis 9:405-410.
83. Fearnhead, N.S., Britton, M.P., and Bodmer, W.F. (2001). The ABC of APC. Hum. Mol. Genet. 10:721-733.
84. Fearon, E.R., and Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell 61:759-767.
85. Fenech, M. (2001). The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat. Res. 475:57-67.
86. Feng. G., Ohmori, Y., and Chang, P.L. (2006). Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-kappaB pathway. Carcinogenesis 27(1):43-52.
87. Fenton, S.E., Hamm, J.T., Birnbaum, L.S., and Youngblood, G.L. (2002). Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 67:63-74.
88. Filipic, M., Fatur, T., and Vudrag, M. (2006). Molecular mechanisms of cadmium induced mutagenicity. Hum. Exp. Toxicol. 25(2):67-77.
89. Friedewald, W.F., and Rous, P. (1944). The initiating and promting elements in tumor production. J. Exp. Med 80:101-125.
90. Fujiki, H., Suganuma, M., Komori, A., Yatsunami, J., Ohta, T., and Sueoka, E. (1994). A new tumor promotion pathway and its inhibitors. Cancer Detect. Prev. 18(1):1-7.
91. Fujiki, H., Suganuma, M., Okabe, S., Sueok, E., Suga, K., Imai, K., and Nakachi, K. (2000). A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea - A review. Cancer Detect Prev. 24(1):91-99.
92. Furstenberger, G., Kinzel, V., and Marks, F. (1985). Partial inversion of the initiation promotion sequence of multistage tumorigenesis in the skin of NMRI mice. Science 230:76-78.
93. Fürstenberger, G., and Kopp-Schneider, A. (1995). Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin. Carcinogenesis 16(1):61-69.
94. Galm, O., Herman, J.G., and Baylin, S.B. (2006). The fundamental role of epigenetics in hematopoietic malignancies Blood Rev. 20(1):1-13.
95. Georgiou, L., Minopoulos, G., Lirantzopoulos, N., Fiska-Demetriou, A., Maltezos, E., and Sivridis, E.J. (2006). Angiogenesis and p53 at the invading tumor edge: Prognostic markers for colorectal cancer beyond stage. Surg. Res. 131(1):118-123.
96. Geter, D.R., Moore, T.M., George, M.H., Kilbur , S.R., Allen, J.W., Nelson, G.M., Winkfield, E., and DeAngelo, A.B. ( 2005). Tribromomethane exposure and dietary folate deficiency in the formation of aberrant crypt foci in the colons of F344/N rats. Food Chem. Toxicol. 43(9):1405-1412.
97. Ghoshal, K., Li, X., Datta, J., Bai, S., Pogribny, I., Pogribny, M., Huang, Y., Young, D., and Jacob, S.T. (2006). A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J. Nutr. 136(6):1522-1527.
98. Glauert, H.P., Eyigor, A., Tharappel, J.C., Copper, S., Lee, E.Y., and Spear, B.T. (2006). Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643. Toxicol. Sci. 90(2):331-336.
99. Glinghammar, B., Inoue, H., and Rafter, J.J. (2002). Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NFkB and AP-1. Carcinogenesis 23:839-845.
100. Go, C., Li, P., and Wang, X.J. (1999). Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: A mechanism associated with increased angiogenesis. Cancer Res. 59(12):2861-2868.
101. Goerttler, K., Loehrke, H., Schweizer, J., and Hesse, B. (1980). Twostage skin carcinogenesis by systemic initiation of pregnant mice with 7,12-dimethylbenz(a)anthracene during gestation days 6-20 and postnatal promotion of the F 1-generation with the phorbol ester 12-tetradecanoylphorbol- 13-acetate. J. Cancer Res. Clin. Oncol. 98(3):267-275.
102. Goldsworthy, T., Campbell, H.A., and Pitot, H.C. (1984). The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis 5:67-71.
103. Goldsworthy, T.L., and Pitot, H.C. (1985). An approach to the development of a short-term whole-animal bioassay to distinguish initiating agents (incomplete carcinogens), promoting agents, comple carcionogens, and noncarcinogens in rat liver. J. Toxicol Environ. Health 16:6063.
104. Goldsworthy, T.L., and Pitot, H.C. (1985). The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital. Carcinogenesis 6:1261-1269.
105. Gonzalez, F.J. (2002). The peroxisome proliferator-activated receptor alpha (PPARalpha): Role in hepatocarcinogenesis. Mol. Cell Endocrinol. 193(1-2):71-79.
106. Gonzalez, F.J., Peters, J.M., and Cattley, R.C. (1998). Mechanism of action of the nongenotoxic peroxisome proliferators:role of the peroxisome proliferator-activator receptor alpha. JNCI 90(22):1702-1709.
107. Gopalan, P., Tsuji, K., Lehmann, K., Kimura, M., Shinozuka, H., Sato, K., and Lotlikar, P.D. (1993). Modulation of aflatoxin B1-induced glutathione S-transferase placental form positive hepatic foci by pretreatment of rats with phenobarbital and buthionine sulfoximine. Carcinogenesis 14(7):1469-1470.
108. Grasl-Kraupp, B., Luebeck, G., Wagner, A., Low-Baselli, A., de Gunst, M., Waldhor, T., Moolgavkar, S., and Schulte-Hermann, R. (2000). Quantitative analysis of tumor initiation in rat liver: Role of cell replication and cell death (apoptosis). Carcinogenesis 21:1411-1421.
109. Gray, J.P., Burns, K.A., Leas, T.L., Perdew, G.H., and Vanden Heuvel, J.P. (2005). Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C. Biochemistry 4(30):10313-10321.
110. Greaves, M.F. (1999). Molecular genetics, natural history and the demise of childhood leukaemia. Eur. J. Cancer 35:1941-1953.
111. Guo, Y.T., Leng, X.S., Li, T., Zhao, J.M., and Lin, X.H. (2004). Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats. World J. Gastroenterol. 10(23):3419-3423.
112. Gupta, K., Kshirsagar, S., Chang, L., Schwartz, R., Law, P.Y., Yee, D., and Hebbel, R.P. (2002). Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 62:4491-4498.
113. Halazonetis, T.D., Gorgoulis, V.G., and Bartek, J. (2008). An oncogeneinduced DNA damage model for cancer development. Science 319:1352-1355.
114. Hara, T., Saito, Y., Hirai, T., Nakamura, K., Nakao, K., Katsuki, M., and Chida, K. (2005). Deficiency of protein kinase C results in impairment of epidermal hyperplasia and enhancement of tumor formation in two-stage skin carcinogenesis. Cancer Res. 65(16):7356-7362.
115. Harada, T., Yamaguchi, S., Ohtsuka, R., Takeda, M., Fujisawa, H., Yoshida, T., Enomoto, A., Chiba, Y., Fukumori, J., Kojima, S., Tomiyama, N., Saka, M., Ozaki, M., and Maita, K. (2003). Mechanisms of promotion and progression of preneoplastic lesions in hepatocarcinogenesis by DDT in F344 rats. Toxicol. Pathol. 31:87-98.
116. Hartwig, A., Asmuss, M., Ehleben, I., Herzer, U., Kostelac, D., Pelzer, A., Schwerdtle, T., and Burkle, A. (2002). Interference by toxic metal ions with DNA repair processes and cell cycle control:Molecular mechanisms. Environ. Health Perspect. 110(suppl. 5):797-799.
117. Haseman, J.K. (2003). An alternative perspective: A critical evaluation of the Waddell threshold extrapolation model in chemical carcinogenesis. Toxicol. Pathol. 31:468-470.
118. Hattis, D. (1990). Pharmacokinetic principles for dose rate extrapolation of carcinogenic risk from genetically active agents. Risk Anal. 10:303-316.
119. Hattis, D. (2008). Distributional analyses for children's inhalation risk assessments. J. Toxicol. Environ. Health A 71(3):218-226.
120. Hattis, D., Goble, R., and Chu, M. (2005). Age-related differences in susceptibility to carcinogenesis. II. approaches for application and uncertainty analyses for individual genetically acing carcinogens. Environ. Health Perspect. 113:509-516.
121. Hattis, D., Goble, R., Russ, A., Chu, M., and Ericson, J. (2004). Age-related differences in susceptibility to carcinogenesis - A quantitative analysis of empirical animal bioassay data. Environ. Health Perspect. 112(11):1152-1158.
122. Hattis, D., and Goble, R.L. (2007). Uncertainties in risk assessment for carcinogenesis:a road map toward practical improvements. White paper for the U.S. Environmental Protection Agency, Washington, DC.
123. Hattis, D., and Silver, K. (1994). Use of mechanistic data in occupational health risk assessment - The example of diesel particulates In Chemical Risk Assessment and Occupational Health - Current Applications, Limitations, and Future Prospects, C.M. Smith, D. C. Christiani, and K. T. Kelsey, ed. 167-177. Westport CT: Greenwood.
124. Hazan, R.B., Qiao, R., Keren, R., Badano, I., and Suyama, K. (2004). Cadherin switch in tumor progression. Ann. NY Acad. Sci. 1014:155-163.
125. Hennings, H., Glick, A.B., Greenhalgh, D.A., Morgan, D.L., Strickland, J.E., Tennenbaum, T., and Yuspa, S.H. (1993). Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proc. Soc. Exp. Biol. Med. 202(1):1-8.
126. Hennings, H., Michael, D., Lichti, U., and Yuspa, S.H. (1987). Response of carcinogen-altered mouse epidermal cells to phorbol ester tumor promoters and calcium. J. Invest. Dermatol. 88(1):60-65.
127. Hennings, H., Shores, R., Wenk, M.L., Spangler, E.F., Tarone, R., and Yuspa, S.H. (1983). Induction of papillomas with a high probability of conversion to malignancy. Nature 304:67-69.
128. Hennings, H., and Yuspa, S.H. (1985). Two-stage tumor promotion in mouse skin: An alternative interpretation. JNCI 74:735-740.
129. Herbst, A.L., Ulfelder, H., and Poskanzer, D.C. (1971). Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284:878-881.
130. Herman, J.G., and Baylin, S.B. (2003). Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349(21):2042-2054.
131. Hilakivi-Clarke, L., Cho, E., Onajafe, I., Liao, D.J., and Clarke, R. (2000). Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clin. Cancer Res. 6:305-308.
132. Hilakivi-Clarke, L., Cho, E., Onajafe, I., Raygada, M., and Clarke, R. (1999). Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol. Rep. 6:1089-1095.
133. Ho, S.M., Tang, W.Y., Belmonte de Frausto, J., and Prins, G.S. (2006). Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 66(11):5624-5632.
134. Hoal-van Helden, E.G., and van Helden, P.D. (1989). Age-related methylation changes in DNA may reflect the proliferative potential of organs. Mutat. Res. 219(5-6):263-266.
135. Hokaiwado, N., Asamoto, M., Ogawa, K., and Shirai, T. (2005a). Transgenic disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat. Toxicol. Pathol. 33(6):695-701.
136. Hokaiwado, N., Asamoto, M., Ogawa, K., and Shirai, T. (2005b). Transgenic disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat. Toxicol. Pathol. 33(6):695-701.
137. Holland er, M.C., Philburn, R.T., Patterson, A.D., Velasco-Miguel, S., Friedberg, E.C., Linnoila, R.I., and Fornace, A.J.J. (2005). Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc. Natl. Acad. Sci. USA 102(37):13200-13205.
138. Holst, C.R., Nuovo, G.J., Esteller, M., Chew, K., Baylin, S.B., Herman, J.G., and Tlsty, T.D. (2003). Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63(7):1596-1601.
139. Hong, E.J., Ji, Y.K., Choi, K.C., Manabe, N., and Jeung, E.B. (2005). Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k. J. Reprod. Dev. 51(2):253-263.
140. Huang, W.W., Yin, Y., Bi, Q., Chiang, T.C., Garner, N., Vuoristo, J., McLachlan, J.A., and Ma, L. (2005). Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol. Endocrinol. 19(3):669-682.
141. Huang, X.P., Fan, X.T., Desjeux, J.F., and Castagn, M. (1992). Bile acids, non-phorbol-ester-type tumor promoters, stimulate the phosphorylation of protein kinase C substrates in human platelets and colon cell line HT29. Int. J. Cancer 52(3):444-450.
142. Iatropoulos, M.J., Wang, C.X., , von Keutz, E., and Williams, G.M. (2006). Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of Nifurtimox, an antitrypanosomiasis drug. Exp. Toxicol. Pathol. 57(5-6):397-404.
143. Imaoka, T., Nishimura, M., Nishimura, Y., Kakinuma, S., and Shimada, Y. (2006). Persistent cell proliferation of terminal end buds precedes radiation-induced rat mammary carcinogenesis. In Vivo 20(3):353-358.
144. Imray, C.H., Radley, S., Davis, A., Barker, G., Hendrickse, C.W., Donovan, I.A., Lawson, A.M., Baker, P.R., and Neoptolemos, J.P. (1992). Faecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut 33(9):1239-1245.
145. Ingelman-Sundberg, M., Ronis, M.J., Lindros, K.O., Eliasson, E., and Zhukov, A. (1994). Ethanol-inducible cytochrome P4502E1: Regulation, enzymology and molecular biology. Alcohol Alcohol. Suppl. 2:131-139.
146. Ingleman-Sundberg, M., Johannson, I., Yin, H., Terelius, Y., Eliasson, E., Clot, P., and Albano, E. (1993). Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 10:447-452.
147. Issa, J.P. (2002). Epigenetic variation and human disease. J. Nutr. 132(8 Suppl.):2388S-2392S.
148. Ito, N., Tamano, S., and Shirai, T. (2003). A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci. 94(1):3-8.
149. Ito, Y., Yamanoshita, O., Asaeda, N., Tagawa, Y., Lee, C.H., Aoyama, T., Ichihara, G., Furuhashi, K., Kamijima, M., Gonzalez, F.J., and Nakajima, T. (2007). Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway. J. Occup. Health 49(3):172-182.
150. Jacinto, F.V., and Esteller, M. (2007). Mutator pathways unleashed by epigenetic silencing in human cancer. Mutagenesis 22(4):247-253.
151. Jinno, H., Steiner, M.G., Nason-Burchenal, K., Osborne, M.P., and Telang, N. (2002). Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells. Int. J. Oncol. 21(1):127-134.
152. Kaaks, R., Berrino, F., Key, T., Rinaldi, S., Dossus, L., Biessy, C., Secreto, G., Amiano, P., Bingham, S., Boeing, H., de Mesquita, H.B.B., Chang-Claude, J., Clavel-Chapelon, F., Fournier, A., van Gils. C.H., Gonzalez,
153. Kampert, J.B., Whittemore, A.S., and Paffenbarger, R.S.J. (1988). Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk. Am. J. Epidemiol. 128:962-979.
154. Kavanaugh, C.J., Liu, K.L., and Belury, M.A. (1999). Effect of dietary conjugated linoleic acid on phorbol ester-induced PGE2 production and hyperplasia in mouse epidermis. Nutr. Cancer 33(2):132-138.
155. Kemp, C.J. (2005). Multistep skin cancer in mice as a model to study the evolution of cancer cells. Semin. Cancer Biol. 15:460-473.
156. Kern, M.A., Schoneweiss, M.M., Sahi, D., Bahlo, M., Haugg, A.M., Kasper, H.U., Dienes, H.P., Kaferstein, H., Breuhahn, K., and Schirmacher, P. (2004). Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice. Carcinogenesis 25(7):1193-1199.
157. Key, T., Appleby, P., Barnes, I., and Reeves, G. (2002). Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. JNCI 94:606-616.
158. Kim, D.J., Bility, M.T., Billin, A.N., Willson, T.M., Gonzalez, F.J., and Peters, J.M. (2006). PPARbeta/delta selectively induces differentiation and inhibits cell proliferation. Cell Death Differ. 13(1):53-60.
159. Kim, Y.I. (2007). Folate and colorectal cancer: An evidence-based critical review. Mol. Nutr. Food Res. 51(3):267-292.
160. Klaunig, J.E., Babich, M.A., Baetcke, K.P., Cook, J.C., Corton, J.C., David, R.M., DeLuca, J.G., Lai, D.Y., McKee, R., Peters, J.M., Roberts, R.A., and Fenner-Crisp, P.A. (2003 ). PPARalpha agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33(6):655-780.
161. Klein-Szanto, A.J.P., and Slaga, T.J. (1981). Numerical variation of dark cells in normal and chemically induced hyperplastic epidermis with age of animal and efficiency of tumor promotor. Cancer Res. 41:4437-4440.
162. Knerr, S., and Schrenk, D. (2006). Carcinogenicity of "non-dioxinlike" polychlorinated biphenyls. Crit. Rev. Toxicol. 36(9):663-694.
163. Ko, C.H., Shen, S.C., Lin, H.Y., Hou, W.C., Lee, W.R., Yang, L.L., and Chen, Y.C. (2002). Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: Involvement of prostagland in E2 in anti-promotive process. J. Cell. Physiol 193:93-102.
164. Kohn, M.C., and Melnick, R.L. (2002). Biochemical origins of the nonmonotonic receptor-mediated dose-response. J. Mol. Endocrinol. 29:113-123.
165. Kohn, M.C., and Portier, C.J. (1993). Effects of the mechanism of receptor-mediated gene expression on the shape of the dose-response curve. Risk Anal. 13:565-572.
166. Kohn, M.C., Walker, N.J., Kim, A.H., and Portier, C.J. (2001). Physiological modeling of a proposed mechanism of enzyme induction by TCDD. Toxicology 162(3):193-208.
167. Kohn, M.C., and Melnick, R.L. (2002). Biochemical origins of the non-monotonic receptor-mediated dose-response. J. Mol. Endocrinol. 29:113-123.
168. Kohno, H., Suzuki, R., Sugie, S., and Tanaka, T. (2005). Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligand s. BMC Cancer 5:46.
169. Konishi, H., Tanaka, M., Takemura, Y., Matsuzaki, H., Ono Y., Kikkawa, U., and Nishizuka, Y. (1997). Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc. Natl. Acad. Sci. USA 94(21):11233-11237.
170. Kopera, E., Schwerdtle, T., Hartwig, A., and Bal, W. (2004). Co(II) and Cd(II) substitute for Zn(II) in the zinc finger derived from the DNA repair protein XPA, demonstrating a variety of potential mechanisms of toxicity. Chem. Res. Toxicol. 17(11):1452-1458.
171. Kraupp-Grasl, B., Huber, W., Taper, H., and Schulte-Hermann, R. (1991). Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res. 51:666-671.
172. Krutovskikh, V.A., Mesnil, M., Mazzoleni, G., and Yamasaki, H. (1995). Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins. Lab. Invest. 72(5):571-577.
173. Krutovskikh, V.A., Piccoli, C., and Yamasaki, H. (2002). Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene 21(13):1989-1999.
174. Kurebayashi, J. (2007). Current clinical trials of endocrine therapy for breast cancer. Breast Cancer 14(2):200-214.
175. Latruffe, N., Cherkaoui Malki, M., Nicolas-Frances, V., Clemencet, M.C., Jannin, B., and Berlot, J.P. (2000). Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases. Biochem. Pharmacol. 60(8):1027-1032.
176. Lauber, S.N., Ali, S., and Gooderham, N.J. (2004). The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen:a mechanistic basis for its tissue-specific carcinogenicity Carcinogenesis 25(12):2509-2517.
177. Layde, P.M., Webster, L., Baughman, A.L., Wingo, P.A., Rubin, G., and Ory, H.W. (1989). The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J. Clin. Epidemiol. 42:963-973.
178. Le Deley, M.C., Suzan, F., Cutuli, B., Delaloge, S., Shamsaldin, A., Linassier, C., Clisant, S., de Vathaire, F., Fenaux, P., and Hill, C. (2007). Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: Risk factors for leukemia and myelodysplastic syndrome after breast cancer. J. Clin. Oncol. 25(3):292-300.
179. Lee, G.H. (2000). Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis. Toxicol. Pathol. 28:215-225.
180. Leithe, E., and Rivedal, E. (2004). Ubiquitination and downregulation of gap junction protein connexin-43 in response to 12-O-tetradecanoylphorbol 13-acetate treatment. J. Biol. Chem. 279(48):50089-50096.
181. Li, C.I., Daling, J.R., and Malone, K.E. (2003). Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J. Clin. Oncol. 21(1):28-34.
182. Li, L.F., Fiedler, V.C., and Kumar, R. (1998). Down-regulation of protein kinase C isoforms in irritant contact dermatitis. Contact Dermatitis 38(6):319-324.
183. Liddell, F.D. (2001). The interaction of asbestos and smoking in lung cancer. Ann. Occup. Hyg. 45(5):341-356.
184. Lightfoot, T.J., and Roman, E. ( 2004). Causes of childhood leukaemia and lymphoma. Toxicol. Appl. Pharmacol. 199(2):104-117.
185. Lock, E.A., and Hard, G.C. (2004). Chemically induced renal tubule tumors in the laboratory rat and mouse: Review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit. Rev. Toxicol. 34(3):211-299.
186. Loeppen, S., Schneider, D., Gaunitz, F., Gebhardt, R., Kurek, R., Buchmann, A., and Schwarz, M. (2002). Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res. 62(20):5685- 5688.
187. Luebeck, E.G., Buchmann, A., Schneider, D., Moolgavkar, S.H., and Schwarz, M. (2005). Modulation of liver tumorigenesis in Connexin32-deficient mouse. Mutat. Res. 570(1):33-47.
188. Lutz, W.K. (1998). Dose-response relationships in chemical carcinogenesis: Superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes. Mutat. Res. 405(2):117-124.
189. Machala, M., Blaha, L., Vondrack, J., Trosko, J.E., Scott, J., and Upham. B, L. (2003). Inhibition of gap juctional intercellular communication by noncoplanar polychlorinated biphenyls: Inhibitory potencies and screeing for potential mode(s) of action. Toxicol. Sci. 76:102-111.
190. Mackay, A.G., Urruticoechea, A., Dixon, J.M., Dexter, T., Fenwick, K., Ashworth, A., Drury, S., Larionov, A., Young, O., White, S., Miller, W.R., Evans, D.B., and Dowsett, M. (2007). Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast Cancer Res. 9(3):R37.
191. Malley, A., and Chipman, J.K. (2002). Non-genotoxic carcinogens: Early effects on gap junctions, cell proliferation and apoptosis in the rat. Toxicol. Appl. Pharmacol. 180(3):233-248.
192. Mancuso, M., Pazzaglia, S., Tanori, M., Rebessi, S., Di Majo, V., Covelli, V., and Saran, A. (2004). Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mutat. Res. 548(1-2):35-45.
193. Maras, M., Vanparys. C., Muylle, F., Robbens, J., Berger, U., Barber, J.L., Blust, R., and De Coen, W. (2006). Estrogen-like properties of fluorotelomer alcohols as revealed by MCF-7 breast cancer cell proliferation. Environ. Health Perspect. 114(1):100-105.
194. Markey, C.M., Luque, E.H., Munoz De Toro, M., Sonnenschein, C., and Soto, A.M. (2001). In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol. Reprod. 65(4):1215-1223.
195. Marks, F., and Fürstenberger, G. (2000). Cancer chemoprevention through interruption of multistage carcinogenesis. The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur. J. Cancer 36(3):314-329.
196. Marks, F., Müller-Decker, K., and Fürstenberger, G. (2000). A causal relationship between unscheduled eicosanoid signaling and tumor development:cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology 153(1-3):11-26.
197. Marquez, A., Villa-Treviño, S., and Guéraud, F. (2007). The LEC rat: A useful model for studying liver carcinogenesis related to oxidative stress and inflammation. Redox Rep. 12(1):35-39.
198. Martin, S., Phillips. D.C, Szekely-Szuck, K., Elghazi, L., Desmots, F., and Houghton, J.A. (2005). Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae. Cancer Res. 65:11447-11458.
199. Masferrer, J. (2001). Approach to angiogenesis inhibition based on cyclooxygenase-2. Cancer J. 2001 7(Suppl. 3):S144-150.
200. Mastrangelo, G., Fedeli, U., Fadda, E., Valentini, F., Agnesi, R., Magarotto, G., Marchi, T., Buda, A., Pinzani, M., and Martines, D. (2004). Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: Synergistic effect of occupational exposure with alcohol intake. Environ. Health Perspect. 112(11):1188-1192.
201. Matsui, M.S., Wang, N., MacFarlane, D., and DeLeo, V.A. (1994). Long-wave ultraviolet radiation induces protein kinase C in normal human keratinocytes. Photochem. Photobiol. 59(1):53-57.
202. McFadden, D., Wright, J.L., Wiggs, B., and Churg, A. (1986). Smoking inhibits asbestos clearance. Am. Rev. Respir. Dis. 133(3):372-374.
203. Meek, M.E., Bucher, J.R., Cohen, S.M., Dellarco, V., Hill, R.N., Lehman-McKeeman, L.D., Longfellow, D.G., Pastoor, T., Seed, J., and Patton, D.E. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33(6):591-653.
204. Melnick, R.L., Kohn, M.C., Dunnick, J.K., and Leininge, J. (1998). Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanes. Toxicol. Appl. Pharmacol. 148(1):137-147.
205. Melnick, R.L., Kohn, M.C., and Portier, C.J. (1996). Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis. Environ. Health Perspect. 104(Suppl. 1):123-134.
206. Merzenich, H., Hartwig, A., Ahrens, W., Beyersmann, D., Schlepegrell, R., Scholze, M., Timm, J., and Karl-Heinz, J. (2001). Biomonitoring on carcinogenic metals and oxidative DNA damage in a cross-sectional study. Cancer Epidemiol. Biomarkers Prevent. 10:515-522.
207. Mesnil, M. (2002). Connexins and cancer. Biol. Cell 94(7-8):493-500.
208. Messner, D.J., Ao, P., Jagdale, A.B., and Boynton, A.L. (2001). Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation. Carcinogenesis 22(8):1163-1172.
209. Meyer, S.A., Moser. G.J., Monteiro-Riviere, N.A., and Smart, R.C. (1993). Minimal role of enhanced cell proliferation in skin tumor promotion by mirex: a nonphorbol ester-type promoter. Environ. Health Perspect. 101(Suppl. 5):265-269.
210. Micu, A.L., Miksys, S., Sellers, E. M., Koop, D. R., and Tyndale, R. F. (2003). Rat hepatic CYP2E1 is induced by very low nicotine doses: An investigation of induction, time course, dose response, and mechanism. J. Pharmacol. Exp. Ther. 306(3):941-947.
211. Milutinovic, S., D'Alessio, A.C., Detich, N., and Szyf, M. (2007). Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 28(3):560-571.
212. Misra, P., Owuor, E., Li, W., Yu, S., Qi, C., Meyer, K., Zhu, Y.J., Rao, M.S., Kong. A.N., and Reddy, J.K. (2002). Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase. J. Biol. Chem. 277(50):48745-48754.
213. Missmer, S.A., Eliassen, A.H., Barbieri, R.L., and Haninson, S.E. (2004). Endogenous estrogen, and rogen, and progesterone concentrations and breast cancer risk among postmenopausal women. JNCI 96:1856-1865.
214. Moennikes, O., Buchmann, A., Romualdi, A., Ott, T., Werringloer, J., and Schwarz, M. (2000. ). Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. Cancer Res. 60:5087-5091.
215. Moennikes, O., Loeppen, S., Buchmann, A., Andersson, P., Ittrich, C., Poellinger, L., and Schwartz, M. (2004). A constitutively active dioxin/arkyl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res. 64:4707-4710.
216. Moennikes, O., Stahl, S., Bannasch, P., Buchmann, A., and Schwarz, M. (2003).WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice. Carcinogenesis 24(9):1561-1565.
217. Möller, W., Barth, W., Kohlhäufl, M., Häussinger, K., Stahlhofen, W., and Heyder, J. (2001). Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in healthy and diseased subjects. Exp. Lung Res. 27(7):547-556.
218. Moolgavkar, S.H., Day, N.E., and Stevens, R.G. (1980). Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. JNCI 65:559-569.
219. Moolgavkar, S.H., and Knudson, A.G.J. (1981). Mutation and cancer: A model for human carcinogenesis. JNCI 66:1037-1052.
220. Moore, M.A., Nakagawa, K., Satoh, K., Ishikawa, T., and Sato, K. (1987). Single GST-P positive liver cells - Putative initiated hepatocytes. Carcinogenesis 8(3):483-486.
221. Mousa, S.A., O'Connor, L., Rossman, T.G., and Block, E. (2007). Proangiogenesis action of arsenic and its reversal by selenium-derived compounds. Carcinogenesis 28(5):962-967.
222. Mukherjee, J.J., and Sikka, H.C. (2006). Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NfkB activation: role of p38 MAP kinase. Carcinogenesis 27:631-638.
223. Munoz-de-Toro, M., Markey, C., Wadia, P.R., Luque, E.H., Rubin, B.S., Sonnenschein, C., and Soto, A. M. (2005). Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology 146(9):4138-4147.
224. Mutch, D.G., Powell, M.A., Mallon, M.A., and Goodfellow, P.J. (2004). RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers. Am. J. Obstet. Gynecol. 190(4):935-942.
225. Muto, T., Wakui, S., Imano, N., Nakaaki, K., Hano, H., Furasato, M., and Masaoka, T. (2001a). In-utero and lactational exposure of 3,3′,4,4′, 5-pentachlorobiphenyl modulate dimethylbenz[a]anthracene-induced rat mammary carcinogenesis. J. Toxicol. Pathol. 14:213-224.
226. Muto, T., Wakui, S., Imano, N., Nakaaki, K., Hano, H., Furasato, M., and Masaoka, T. (2001b). In-utero and lactational exposure of 3,3′,4,4′, 5-pentachlorobiphenyl modulate dimethylbenz[a]anthracene-induced rat mammary carcinogenesis. J. Toxicol. Pathol. 14:213-224.
227. Muto, T., Wakui, S., Imano, N., Nakaaki, K., Takahashi, H., Hano, H., Furusato, M., and Masaoka. T. (2002). Mammary gland differentiation in female rats after prenatal exposure to 3,3′,4,4′,5-pentachlorobiphenyl. Toxicology 177(2-3):197-205.
228. Nagi, C., Guttman, M., Jaffer, S., Qiao, R., Keren, R., Triana, A., Li, M., Godbold, J., Bleiweiss, I.J. and Hazan, R.B. (2005). N-cadherin expression in breast cancer: Correlation with an aggressive histologic variant-Invasive micropapillary carcinoma. Breast Cancer Res. Treat. 94(3):225-235.
229. Nakadate, T. (1989). The mechanism of skin tumor promotion caused by phorbol esters:possible involvement of arachidonic acid cascade/lipoxygenase, protein kinase C and calcium/calmodulin systems. Jpn. J. Pharmacol. 49(1):1-9.
230. Nakajima, T., Kamijo, Y., Usuda, N., Liang, Y., Fukushima, Y., Kametani, K., Gonzalez, F.J., and Aoyama, T. (2000). Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor alpha (PPARalpha). Carcinogenesis 21(4):677-682.
231. Narayan, S., and Roy, D. (2003). Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol. Cancer 2:41. Available http://ntp.niehs.nih.gov/?objectid=03F36FEFD2A2-D1FB-EDC8D976FF64BEA6
232. National Research Council. (2006). Assessing the human health risks of trichloroethylene: Key scientific issues, Board of Environmental Studies and Toxicology, Appendix E, p. 419. National Academy Press, Washington, DC.
233. National Research Council. (2007). Toxicity testing in the twenty-first century: A vision and a strategy. National Academy Press, Washington, DC.
234. National Toxicology Program. (1993). Toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 77-47-4) in B6C3F1 mice (Inhalation studies). NTP TR-434.
235. National Toxicology Program. (1999). Toxicology and carcinogenesis studies of pentachlorophenol (CAS No. 87-86-5) in F344/N rats (Feed studies). NTP TR-483. Available http://ntp.niehs.nih.gov/?objectid=03F4BEF4-BFE4-9804- 59B26EDB4160994C
236. Newbold, R.R. (2004). Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol. Appl. Pharmacol. 199(2):142-150.
237. Nishida, N., Nishimura, T., Nagasaka, T., Ikai, I., Ajay, G., and Boland, C.R. (2007). Extensive methylation is associated with β-catenin mutations in hepatocellular carcinoma: Evidence for two distinct pathways of human hepatocarcinogenesis Cancer Res. 67:4586-4594.
238. Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9(7):484-496.
239. Nishizuka, Y. (1984). The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693-698.
240. Novakovic, P., Stempak, J.M., Sohn, K.J., and Kim, Y.I. (2006). Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis 27(5):916-924.
241. Nuovo, G.J., Plaia, T.W., Belinsky, S.A., Baylin, S.B., and Herman, J. G. (1999). In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl. Acad. Sci. USA 96(22):12754-12759.
242. O'Connell, J.F., Rotstein, J.B., and Slaga, T.J. (Eds.). (1987). Nongenotoxic Mechanisms in Carcinogenesis. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
243. Oesch-Bartlomowicz, B., Huelster, A., Wiss, O., Antoniou-Lipfert, P., Dietrich, C., Arand, M., Weiss, C., Bockamp, E., and Oesch, F. (2005). Aryl hydrocarbon receptor activation by cAMP vs. dioxin:divergent signaling pathways. Proc. Natl. Acad. Sci. USA 102(26):9218-9223.
244. Ohshima, H., Tazawa, H., Sylla, B.S., and Sawa, T. (2005). Prevention of human cancer by modulation of chronic inflammatory processes. Mutat. Res. 591(1-2):110-122.
245. Olsen, C.M., Meussen-Elholm, E.T.M., Hongslo, J.K., Stnersen, J., and Tollefsen, K.E. (2005). Estrogenic effects of environmental chemicals: An interspecies comparison. Comp. Biochem. Physiol. C 141:267-274.
246. Ono, T., Yamamoto, S., Kurishita, A., Yamamoto, K., Yamamoto, Y., Ujeno, Y., Sagisaka, K., Fukui, Y., Miyamoto, M., and Tawa, R. (1990). Comparison of age-associated changes of c-myc gene methylation in liver between man and mouse. Mutat. Res. 237(5-6):239-246.
247. Oshima, M., Dinchuk, J.E., Kargman, S.L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J.M., Evans, J.F., and Taketo, M.M. (1996). Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803-809.
248. Ou, Y.C., Conolly, R.B., Thomas, R.S., Xu, Y., And ersen, M.E., Chubb, L. S., Pitot, H.C., and Yang, R.S. (2001). A clonal growth model: Time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay. Cancer Res. 61(5):1879-1889.
249. Palmer, J.R., Wise, L.A., Hatch, E.E., Troisi, R., Titus-Ernstoff, L., Strohsnitter, W., Kaufman, R., Herbst, A.L., Noller, K.L., Hyer, M., and Hoover, R.N. (2006). Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 15(8):1509-1514.
250. Pasquinelli, P., Bruschi, F., Saviozzi, F., and Malvaldi, G. (1985). Immunosuppressive effects and promotion of hepatic carcinogenesis by thiobenzamide. Boll. Soc. Ital. Biol. Sper. 61:61-66.
251. Patel, R.D., Kim, D.J., Peters, J.M., and Perdew, G.H. (2006). The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. Toxicol. Sci. 89(1):75-82.
252. Patel, R.R., Sharma, C.G., and Jordan, V.C. (2007). Optimizing the antihormonal treatment and prevention of breast cancer. Breast Cancer 14(2):113-122.
253. Paumelle, R., Blanquart, C., Briand , O., Barbier, O., Duhem, C., Woerly, G., Percevault, F., Fruchart, J. C., Dombrowicz, D., Glineur, C., and Staels, B. (2006). Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ. Res 98(3):361-369.
254. Pegram, R.A., And ersen, M.E., Warren, S.H., Ross, T.M., and Claxton, L.D. (1997). Glutathione-S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium TA1535: Contrasting results with bromodichloromethane and chloroform. Toxicol. Appl. Pharmacol. 144:183-188.
255. Peng, J., Bowden, G.T., and Domann, F.E. (1997). Activation of AP-1 by okadaic acid in mouse keratinocytes associated with hyperphosphorylation of c-jun. Mol. Carcinogen. 18(1):37-43.
256. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., and Comoglio, P.M. (2003). Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3(4):347-361.
257. Peraza, M.A., Burdick, A.D., Marin, H.E., Gonzalez, F.J., and Peters, J.M. (2006). The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol. Sci. 90(2):269-295.
258. Pereira, M.A., Klaunig, J.E., Herren-Freund, S.L., and Ruch, R.J. (1986). Effect of phenobarbital on the development of liver tumors in juvenile and adult mice. JNCI 77(2):449-452.
259. Pereira, M.A., Wang, W., Kramer, P.M., and Tao, L. (2004). Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice. Toxicol. Sci. 77:243-248.
260. Peters, J.M., Cattley, R.C., and Gonzalez, F.J. (1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18(11):2029-2033.
261. Peters, J.M., Cheung, C. and Gonzalez, F.J. (2005). Peroxisome proliferator-activated receptor-alpha and liver cancer: Where do we stand? J. Mol. Med. 83(10):774-785.
262. Pitot, H.C., and Campbell, H.A. (Eds.). (1987). Quantitative studies on multistage hepatocarcinogenesis in the rat. Raven Press, New York.
263. Pogribny, I.P., Ross, S.A., Wise, C., Pogribna, M., Jones, E.A., Tryndyak, V.P., James, S.J., Dragan, Y.P., and Poirier, L.A. (2006). Irreversible global DNA hypomethylation is a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat. Res. 593:80-87.
264. Ponz de Leon, M., and Percesepe, A. (2000). Pathogenesis of colorectal cancer. Dig. Liver Dis. 32(9):807-821.
265. Portier, C., Tritscher, A., Kohn, M., Sewall, C., Clark, G., Edler, L., Hoel, D., and Lucier, G. (1992). Ligand /receptor binding for 2,3,7,8-TCDD: Implications for risk assessment. Fundam. Appl. Toxicol. 20:48-56.
266. Portier, C.J., Sherman, C.D., Kohn, M., Edler, L., Kopp-Schneider, A., Maronpot, R. M., and Lucier, G. (1996). Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD. Toxicol. Appl. Pharmacol. 138(1):20-30.
267. Prins, G.S., Birch, L., Tang, W.Y., and Ho, S.M. (2007). Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol. 23(3):374-382.
268. Pulukuri, S., and Sitaramayya, A. (2004). Retinaldehyde, a potent inhibitor of gap junctional intercellular communication. Cell Commun. Adhes. 11(1):25-33.
269. Radike, M.J., Stemmer, K.L., and Bingham, E. (1981). Effect of ethanol on vinyl chloride carcinogenesis. Environ. Health Perspect. 41:59-62.
270. Rasmussen, T.H., Nielsen, F., Andersen, H.R., Nielsen, J.B., Weihe, P., and Grandjean, P. (2003). Assessment of xenoestrogenic exposure by a biomarker approach: Application of the E-Screen bioassay to determine estrogenic response of serum extracts. Environ. Health 2(1):12.
271. Ravdin, P.M., Cronin, K.A., Howlader, N., Berg, C.D., Chlebowski, R. T., Feuer, E.J., Edwards, B.K., and Berry, D.B (2007). The decrease in breast-cancer incidence in 2003 in the United States. N. Engl. J. Med. 356:1670-1674.
272. Reiners, J.J.J., and Slaga, T.J. (1983). Effects of tumor promoters on the rate and commitment to terminal differentiation of subpopulations of murine keratinocytes. Cell 32(1):247-255.
273. Ren, P., and Ruch, R.J. (1996). Inhibition of gap junctional intercellular communication by barbiturates in long-term primary cultured rat hepatocytes is correlated with liver tumour promoting activity. Carcinogenesis 17(10):2119-2124.
274. Richardson, D.B. (2008). Temporal variation in the association between benzene and leukemia mortality. Environ. Health Perspect. 116(3):370-374.
275. Rivedal, E, and Leithe, E. (2005). Connexin43 synthesis, phosphorylation, and degradation in regulation of transient inhibition of gap junction intercellular communication by the phorbol ester TPA in rat liver epithelial cells. Exp. Cell Res. 302(2):143-152.
276. Rivedal, E., and Witz, G. (2005). Metabolites of benzene are potent inhibitors of gap-junction intercellular communication. Arch. Toxicol. 79(6):303-311.
277. Roberts, R., Ganey, P., Ju, C., Kamendulis, L. M., Rusyn, I., and Klaunig, J.E. (2007). Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol. Sci. 6(1):2-15.
278. Rodriguez-Puebla, M. L., Miliani de Marval, P. L., LaCava, M., Moons, D. S., Kiyokawa, H., and Conti, C.J. (2002). Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation. Am. J. Pathol. 161(2):405-411.
279. Rosenberg, M. P. (1997). Gene knockout and transgenic technologies in risk assessment: The next generation. Mol. Carcinogen. 20:262-274.
280. Ross, J.A. (1998). Maternal diet and infant leukemia: A role for DNA topoisomerase II inhibitors? . Int. J. Cancer Suppl. 11:26-28.
281. Russo, J., and Russo, I.H. (1996). Experimentally induced mammary tumors in rats. Breast Cancer Res. Treat. 39(1):7-20.
282. Russo, J., Tay, L.K., and Russo, I.H. (1982). Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat. 2(1):5-73.
283. Rusyn, I., Kadiiska, M.B., Dikalova, A., Kono, H., Yin, M., Mason, R.P., Peters, J.M., Gonzalez, F.J., Segal, B.H., Holland , S.M., and Thurman R.G. (2001). Phthalates rapidly increase production of reactive oxygen species in vivo: Role of Kupffer cells. Mol. Pharmacol. 59(4):744-750.
284. Safe, S. (2001). Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol. Lett. 120(1-3):1-7.
285. Sanz-Cameno, P., Martin-Vilchez, S., Lara-Pezzi, E., Borque, M.J., Salmeron, J., Munoz de Rueda, P., Solis, J.A., Lopez-Cabrera, M., and Moreno-Otero, R. (2006). Am. J. Pathol. 169(4):1215-1222.
286. Sasaki, S., and Fukuda, N. (2005 ). Temporal variation of excess mortality rate from solid tumors in mice irradiated at various ages with gamma rays. J. Radiat. Res. 46:1-9.
287. Savarese, T.M., Low, H. P., Baik, I., Strohsnitter, W.C., and Hsieh, C.C. (2006). Normal breast stem cells, malignant breast stem cells, and the perinatal origin of breast cancer. Stem Cell Rev. 2(2):103-110.
288. Schwarz, M., Wanke, I., Wulbrand , U., Moennikes, O., and Buchmann, A. (2003). Role of connexin32 and beta-catenin in tumor promotion in mouse liver. Toxicol. Pathol. 31(1):99-102.
289. Sesardic, D., Boobis, A.R., Edwards, R.J. and Davies, D.S. (1988). A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26:363-372.
290. Shackelford, R.E., Kaufmann, W.K., and Paules, R.S. (1999). Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ. Health Perspect. 107(Suppl. 1):5-24.
291. Shafie, S.M. (1980). Estrogen and the growth of breast cancer: New evidence suggests indirect action. Science 209(4457):701-702.
292. Sjoblom, T., Jones, S., Wood, L.D., Parsons, D.W., Lin, J., Barber, T.D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S. D., Willis, J., Dawson, D., Willson, J.K.V., Gazdar, A.F, Hartigan, J., Wu. L, Liu, C., Parmigiani, G., Park, G.H., Bachman, K.E., Papadopoulos, N., Vogelstein, B., Kinzler, K.W., and Velculescu, V.E. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
293. Skibola, C.F., Smith, M.T., Kane, E., roman, E., Rollinson, S., Cartwright, R.A., and Mortan, G. (1999). Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl. Acad. Sci. USA 96:12810- 12815.
294. Slaga, T.J., DiGiovanni, J., Winberg, L.D. and Budunova, I.V. (1995). Skin carcinogenesis: Characteristics, mechanisms, and prevention. Prog. Clin. Biol. Res. 391:1-2.
295. Slaga, T.J., Fischer, S.M., Nelson, K., and Gleason, G.L. (1980a). Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion. Proc. Natl. Acad. Sci. USA 77:3659-3663.
296. Slaga, T.J., Klein-Szanto, J.P., Fischer, S.M., Weeks, C.E., Nelson, K., and Major, S. (1980b). Studies on mechanism of action of anti-tumor-promoting agents: Their specificity in two-stage promotion. Proc. Natl. Acad. Sci. USA 77:2251-2254.
297. Slaga, T.J., and Scribner, J. D. (1973). Inhibition of tumor initiation and promotion by anti-inflammatory agents. JNCI 51(5):1723-1725.
298. Sonich-Mullin, C., Fielder, R., Wiltse, J., , Baetcke, K., Dempsey, J., Fenner-Crisp, P., Grant, D., Hartley, M., Knaap, A., Kroese, D., Mangelsdorf, I., Meek, E., Rice, J.M., and Younes, M. (2001). International Programme on Chemical Safety,(2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34(2):146-152.
299. Spector, L.G., Xie, Y., Robison, L.L., Heerema, N.A., Hilden, J.M., Lange, B., Felix, C.A., Davies, S.M., Slavin, J., Potter, J. D., Blair, C. K., Reaman, G.H., and Ross, J. A. ( 2005). Maternal diet and infant leukemia:the DNA topoisomerase II inhibitor hypothesis: A report from the children's oncology group. Cancer Epidemiol. Biomarkers Prev. 14(3):651-655.
300. Steele, V.E., and Kelloff, G.J. (2005). Development of cancer chemopreventive drugs based on mechanistic approaches. Mutat. Res. 591:16-23.
301. Steinmetz, R., Young, P. C., Caperell-Grant, A., Gize, E.A., Madhukar, B.V., Ben-Jonathan, N., and Bigsby, R.M. (1996). Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Cancer Res. 56(23):5403-5409.
302. Stoner, G., Casto, B., Ralston, S., Roebuck, B., Pereira, C., and Bailey, G. (2002). Development of a multi-organ rat model for evaluating chemopreventive agens: Efficacy of indole-3-carbinol. Carcinogenesis 23:265-272.
303. Strathmann, J., Schwarz, M., Tharappel, J.C., Glauert, H.P., Spear, B.T., Robertson, L.W., Appel, K.E., and Buchmann, A. (2006). PCB 153, a non-dioxin-like tumor promoter, selects for beta-catenin (Catnb)-mutated mouse liver tumors. Toxicol. Sci. 93(1):34-40.
304. Suganuma, M., Okabe, S., Marino, M.W., Sakai, A., Sueoka, E., and Fujiki, H. (1999). Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res. 59(18 ):4516-4518.
305. Sui, M., Huang, Y., Park, B.H., Davidson, N.E., and Fan, W. (2007). Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. Cancer Res. 67(11):5337-5344.
306. Swann, J.B., and Smyth, M.J. (2007). Immune surveillance of tumors. J. Clin. Invest. 117(5):1137-1146.
307. Swann, P.F., Coe, A.M., and Mace, R. (1984). Ethanol and dimethylnitrosamine and diethylnitrosamine metabolism and disposition in the rat. Possible relevance to the influence of ethanol on human cancer incidence. Carcinogenesis 10:1337-1343.
308. Takahashi, M., Nishimura, S., Miyajima, K., Sasahara, K., Yoshida. M., and Maekawa, A. (2001). Time-dependent promotion activity of 17beta-estradiol on uterine carcinogenesis in mice initiated with N-ethyl-N-nitrosourea. Cancer Lett. 165(2):123-130.
309. Tao, L., Yang, S., Xie, M., Kramer, P.M., and Pereira, M.A. (2000). Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: Prevention by methionine. Toxicol. Sci. 54(2):399-407.
310. Temme, A., Buchmann, A., Gabriel, H.D., Nelles, E., Schwarz, M., and Willecke, K. (1997). High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr. Biol. 7:713-716.
311. Tesarik, J., Garrigosa, L., and Mendoza, C. (1999). Estradiol modulates breast cancer cell apoptosis:a novel nongenomic steroid action relevant to carcinogenesis. Steroids 64(1-2):22-27.
312. Tharappel, J.C., Lee, E.Y., Robertson, L.W., Spear, B.T., and Glauert, H.P. (2002). Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 179(3):172- 184.
313. Thompson, E.J., Gupta, A., Stratton, M.S., and Bowden, G.T. (2002a). Mechanism of action of a dominant negative c-jun mutant in inhibiting activator protein-1 activation. Mol. Carcinogen. 35(4):157-162.
314. Thompson, E.J., MacGowan. J., Young, M.R., Colburn, N., and Bowden, G.T. (2002b). A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion. Cancer Res. 62(11):3044-3047.
315. Tiano, H. F., Loftin, C.D., Akunda, J., Lee, C.A., Spalding, J., Sessoms, A., Dunson, D.B., Rogan E.G., Morham, S.G., Smart, R.C., and Langenbach, R. (2002). Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 62(12):3395-3401.
316. Tlsty, T.D., Crawford Y.G., Holst, C.R., Fordyce, C.A., Zhang, J., McDermott, K., Kozakiewicz, K., and Gauthier, M.L. (2004). Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. Mammary Gland Biol. Neoplasia 9(3):263-274.
317. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J.G., Baylin, S.B., and Issa, J.P. (1999). CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96(15):8681-6866.
318. Trosko, J.E. (2007). Gap junctional intercellular communication as a biological "Rosetta stone" in understand ing, in a systems biological manner, stem cell behavior, mechanisms of epigenetic toxicology, chemoprevention and chemotherapy. J. Membr. Biol. 218(1-3):93-100.
319. Trosko, J.E., Chang, C.C., Upham, B.L., and Tai, M.H. (2004). Ignored hallmarks of carcinogenesis: Stem cells and cell-cell communication. Ann. NY Acad. Sci. 1028:192-201.
320. Trosko, J.E., Chang, C.C., Upham, B.L., and Tai, M.H. (2005). The role of human adult stem cells and cell-cell communication in cancer chemoprevention and chemotherapy strategies. Mutat. Res. 591:187-197.
321. Trosko, J.E., and Chang, C.C. (2001). Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mutat. Res. 480-481:219-229.
322. Tsuji, S., Kawai, N., Tsujii, M., Kawano, S., and Hori, M. (2003). Review article:inflammation-related promotion of gastrointestinal carcinogenesis - A perigenetic pathway. Aliment Pharmacol. Ther. Suppl. 1:82-89.
323. Tsushimoto, G., Chang, C.C., Trosko, J.E., and Matsumura, F. (1983). Cytotoxic, mutagenic, and cell-cell communication inhibitory properties of DDT, lindane, and chlordane on Chinese hamster cells in vitro. Arch. Environ. Contam. Toxicol 12:721-729.
324. Tsutsumi, M., George, J., Ishizawa, K., Fukumura, A., and Takase, S. (2006). Effect of chronic dietary ethanol in the promotion of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. J. Gastroenterol. Hepatol. 21(5):805-813.
325. Tsutsumi, M., Lasker, J.M., Takahashi, T., and Lieber, C.S. (1993). In vivo induction of hepatic P4502E1 by ethanol:role of increased enzyme synthesis. Arch. Biochem. Biophys. 304(1):209-218.
326. U.S. Environmental Protection Agency, (2005a). Guidelines for carcinogen risk assessment. EPA/630/P-03/001B. U.S. EPA, Washington, DC.
327. U.S. Environmental Protection Agency. (2005b). Supplemental guidance for assessing cancer susceptibility from early-life exposure to carcinogens. EPA/630/R-03/003F, March. U.S. EPA, Washington, DC.
328. Uddin, A.N., Burns, F.J., Rossman, T.G., Chen, H., Kluz, T., and Costa, M. (2007). Dietary chromium and nickel enhance UV-carcinogenesis in skin of hairless mice. Toxicol. Appl. Pharmacol. 227:329-333.
329. Umemura, T., Kai, S., Hasegawa, R., Sai, K., Kurokawa, Y., and Williams, G.M. (1999). Pentachlorophenol (PCP) produces liver oxidative stress and promotes but does not initiate hepatocarcinogenesis in B6C3F1 mice. Carcinogenesis 20(6):1115-1120.
330. Walker, N.J., Crockett, P.W., Nyska, A., Brix, A.E., Jokinen, M.P., Sells, D.M., Hailey, J.R., Easterling, M., Haseman, J.K., Yin, M., Wyde, M.E., Bucher, J.R., and Portier, C.J. (2005). Dose-additive carcinogenicity of a defined mixture of dioxin-like compounds. Environ. Health Perspect. 113:43-48.
331. Ward, J.M. (1983). Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms. JNCI 71(4):815-823.
332. Ward, J.M., Lynch, P., and Riggs, C. (1988). Rapid development of hepatocellular neoplasms in aging male C3H/HeNCr mice given phenobarbital. Cancer Lett. 39(1):9-18.
333. Wasson, G.R., McGlynn, A.P., McNulty, H., O'Reilly, S.L., McKelvey-Martin, V.J., McKerr, G., Strain, J.J., Scott, J., and Downes, C.S. (2006). Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation. J. Nutr. 136(11):2748-2753.
334. Watson, M.A., Devereux, T.R., Malarkey, D.E., Anderson, M.W., and Maronpot, R.R. (1995). H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells. Carcinogenesis 16(8):1705-1710.
335. Weghorst, C.M., and Klaunig, J.E. (1989). Phenobarbital promotion in diethylnitrosamine-initiated infant B6C3F1 mice: Influence of gender. Carcinogenesis 10(3):609-612.
336. Wei, M., Morimura, K., Wanibuchi, H., Shen, J., Salim, E.I., Moku, M., Hakoi, K., and Fukushima, S. (2005). JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats. Int. J. Cancer 113(3):354-358.
337. Weisburger, J.H., Reddy, B.S., Barnes, W.S., and Wynder, E.L. (1983). Bile acids, but not neutral sterols, are tumor promoters in the colon in man and in rodents. Environ. Health Perspect. 50:101-107.
338. Weisburger, J.H., and Williams, G. M. (1983). The distinct health risk analyses required for genotoxic carcinogens and promoting agents. Environ. Health Perspect. 50:233-245.
339. Weiss, H.A., Potischman, N.A., Brinton, L.A., Brogn, D., Coates, R.J., Gammon, M.D., Malone, K.E., and Schoenberg, J.B. (1997). Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology 8:181-187.
340. Weitzman, S., Williams, T., Herman, J., and Baylin, S.B. (2004). Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Cancer Res. 64(5):1611-1620.
341. Wheeler, D.L., Ness, K.J., Oberley, T.D., and Verma, A.K. (2003). Protein kinase C epsilon is linked to 12-O-tetradecanoylphorbol-13-acetate- induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice. Cancer Res. 63(19):6547-6555.
342. Williams, G.M. (1983). Epigenetic effects of liver tumor promoters and implications for health effects. Environ. Health Perspect. 50:177-183.
343. Wolfle, D., Marotzki, S., Dartsch, D., Schafer, W., and Marquardt. H. (2000). Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 21(1):15-21.
344. Wölfle, D., and Marquardt, H. (1996). Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8- tetrachlorodibenzo-p-dioxin. Carcinogenesis 17(6):1273- 1278.
345. Wong, H.P., Yu, L., Lam, E.K., Tai, E.K., Wu, W.K., and Cho, C.H. (2007). Nicotine promotes colon tumor growth and angiogenesis through β-adrenergic activation. Toxicol. Sci. 97(2):279-287.
346. Yamada, Y., Jackson-Grusby, L., Linhart, H., Eden, A., Lin, H., and Jaenisch, R. (2005). Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. USA 102(38):13580- 13585.
347. Yamamoto, Y., Moore, R., Goldsworthy, T.L., Negishi, M., and Maronpot, R.R. (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by Phenobarbital in mice. Cancer Res. 64:7197-7200.
348. Yang, Q., Ito, S., and Gonzalez, F.J. (2007). Hepatocyte-restricted constitutive activation of PPARα induces hepatoproliferation but not hepatocarcinogenesis. Carcinogenesis 28(6):1171-1177.
349. Yotti, L.P., Chang, C.C., and Trosko, J.E. (1979). Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 206(4422):1089-1091.
350. Yuspa, S.H., Ben, T., and Hennings, H. (1983). The induction of epidermal transglutaminase and terminal differentiation by tumor promoters in cultured epidermal cells. Carcinogenesis 4(11):1413-1418.
351. Yuspa, S.H., Ben, T., Hennings, H., and Lichti, U. (1982). Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 42(6):2344-2349.
352. Yuspa, S.H., Hennings, H., Tucker, R.W., Jaken, S., Kilkenny, A.E., and Roop, D.R. (1988). Signal transduction for proliferation and differentiation in keratinocytes. Ann. NY Acad. Sci. 548:191-196.
353. Yuspa, S.H., and Morgan, D.L. (1981). Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogeness. Nature 293:72-74.
354. Zakour, R.A., Kunkel, T., and Loeb, L.A. (1981). Metal-induced infidelity of DNA synthesis. Environ. Health Perspect. 40:197-206.